Elligo Health Research vs Emulate
Side-by-side comparison of AI visibility scores, market position, and capabilities
Clinical Trial Enablement & Patient Recruitment
Elligo Health Research brings clinical trials into healthcare settings by using EHR data for patient identification and providing site infrastructure; enables physicians to conduct trials without becoming dedicated research sites;
About
Elligo Health Research is a clinical research organization (CRO) and technology company founded in 2016 and headquartered in Austin, Texas, that embeds clinical trials within existing healthcare environments rather than requiring dedicated research centers. The company's model enables practicing physicians and health systems to conduct clinical trials for their own patients by providing the infrastructure, personnel, regulatory expertise, and data integration needed to run trials — without requiring those providers to become stand-alone research sites. This "research-in-care" approach significantly broadens the pool of potential trial sites and patients.
Pioneering organ-on-chip platform installed in 150+ labs including 17 of the top 25 biopharma companies; launched AVA™ high-throughput 96-chip system in 2025 and holds the only FDA ISTAND-accepted DILI Organ-Chip.
About
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the microstructure and function of human organs. Founded in 2013 as a spin-out from the Wyss Institute at Harvard University, Emulate's chips model the liver, intestine, lung, kidney, brain, and other organ systems with a fidelity that animal models and traditional cell culture cannot match. The technology was originally developed to reduce drug development attrition rates caused by poor translation from animal studies to human clinical outcomes.
AI Visibility Head-to-Head
Key Details
Also Compare
Elligo Health Research vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.